DIABETIC MACULAR EDEMA

This study is testing an oral medication called SNP318 for people with diabetic macular edema, a condition where fluid builds up in the eye and causes vision problems. About 60 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces…

This study is testing if a new drug called AVT29 is as effective and safe as the standard treatment, Eylea HD, for diabetic macular edema, a condition that causes vision loss. About 256 adults with this specific type of vision loss from diabetes will be randomly assigned to recei…

This study is testing whether a probiotic supplement can help control diabetic macular edema, a swelling in the back of the eye that can cause vision loss. 36 adults with this condition will take the probiotic pill twice a day for four months. Researchers will check if the eye sw…

This study aims to find the best laser setting to safely reduce swelling in the back of the eye (macular edema) caused by diabetes. It will compare two different laser pulse patterns in 50 adults with this condition. The goal is to control the disease and protect vision by findin…

This is an early-stage study to check the safety and how the body handles a new drug called RO7823653 for diabetic macular edema (DME), a cause of vision loss. About 93 people with DME will receive injections of the new drug into the eye, either by itself or alongside an existing…

This early-stage study is testing whether a medicine called octreotide, delivered as a nasal spray, can safely reduce swelling in the back of the eye (macular edema) caused by diabetes. It is for people whose eye swelling hasn't improved enough with the standard treatment of inje…

This study aims to see if a new type of wide-field eye scanner (OCTA) can help doctors better diagnose and monitor a range of eye diseases. It will involve 200 participants, some with conditions like macular degeneration or diabetic retinopathy and some healthy controls. Research…

This study aims to see if special eye scans can detect early signs of retinal damage in people with diabetes who have no vision problems. Researchers will compare scans from 112 participants—half with diabetes and half without—to look for subtle changes. The goal is to improve ea…